Several powerful mechanisms exist to prevent self-reactive B cells from maturing to secrete potentially destructive autoantibodies. These mechanisms act in addition to the removal of self-reactive helper T cells.
Large numbers of B cells are produced in the bone marrow throughout life, but very few become mature B cells. Most B-cell death is the result of a normal developmental process which removes the excess of immature B cells that enter secondary lymphoid organs, such as the spleen and lymph nodes. Within the pool of immature B cells, there will be some that bear self-reactive antigen receptors, which can bind to molecules found in healthy body tissues. There is now considerable evidence to show that various specific mechanisms actively remove autoreactive B cells from the repertoire, before they have a chance to mature into cells that secrete autoantibodies.
During the production of B cells from haemopoietic stem cells, DNA rearrangements combine variable-and constant-region gene segments to create the genes that encode the immunoglobulin heavy and light chains. The total repertoire of heavy and light chains that can be generated by this process is very large, but each B cell carries only one functional immunoglobulin light chain and one functional heavy chain gene rearrangement. Consequently, the 105 or so immunoglobulin molecules expressed by a B cell on its surface, which are the cell's antigen-specific receptors, have only one specificity. Activation of a B cell through its surface receptors can start a series of reactions that leads to proliferation, followed by differentiation of the cell's progeny into antibody-secreting cells (plasma cells) or memory B cells. The antigen-binding portion of the secreted antibody is encoded by the same rearranged variable-region gene segments as the surface receptors, and so has the same specificity.
Some immunoglobulin gene rearrangements produce B cells with receptors that bind to foreign molecules such as those associated with pathogenic bacteria or viruses. When stimulated, B cells of this type produce antibodies that can prevent or limit infection. But gene rearrangement can also lead to the production of immunoglobulin that binds to 'self' molecules found within the healthy body. Activation of self-reactive antigen receptors results in the production of autoantibodies that might cause disease. In Graves disease, for example, over-activity of the thyroid results from the action of an autoantibody that mimics the action of thyroid-stimulating hormone by recognizing and binding to the hormone receptor in the thyroid, leading to over-production of the thyroid hormone, thyroxin. Some forms of haemolytic anaemia are also caused by autoimmune reactions in which red blood cells are destroyed following the binding of autoantibodies to one of their surface molecules.
Most of us, however, avoid producing autoantibodies. This results mainly from mechanisms that cause the death of autoreactive T and B cells soon after they first express antigen-specific receptors and before they can be triggered to become effector cells (in the case of T cells) or antibody-secreting cells. The processes that select and weed out self-reactive T cells during their development in the thymus have been the subject of intense investigation. Less work has been directed at the study of the elimination or inactivation of autoreactive B cells. It is often assumed that tolerance to autoantigens is due entirely to the removal of autoreactive T cells, including those that would provide the help needed to stimulate autoreactive B cells to produce antibody, but this is not the case. There is clear evidence that direct selection also occurs in favour of B cells that are not self-reactive (Table 1) .
Pre-B cells become newly produced, virgin B cells when they first express immunoglobulin on their surface: It has long been realized that stimulation of the antigen receptor at this stage can cause cells to die without leaving the marrow. This has been demonstrated experimentally by crosslinking this surface receptor with antibody against the constant region of surface immunoglobulin (Table 1 ) [1] . Nemazee and Biirki [2] demonstrated a similar phenomenon in mice carrying transgenes encoding the heavy and light chains of an antibody against a normal self cellsurface antigen -a class I major histocompatibility complex (MHC) molecule that is expressed on almost all cells in the body, including those in the bone marrow. The transgenes in these mice were expressed in most B cells, and so virtually all B cells carried antigen receptors specific for the self MHC molecule. All these B cells died without leaving the marrow, presumably as a result of interaction with the self antigen carried on bone marrow cells.
Goodnow, Basten and colleagues [3, 4] have identified an additional mechanism that results in inactivation of autoreactive B cells at a later stage of development. They used mice that carried three transgenes; two encoded the heavy and light chains of an antibody against hen egg lysozyme, and the third encoded lysozyme itself. A variety of results are obtained with this system, depending on the way lysozyme is expressed by the mice (see Table 2 ). If lysozyme is present on the surface of cells, the newly produced anti-lysozyme-specific B cells die without leaving the marrow [4] . This is similar to the effect described above, in which autoreactive B cells are deleted in Nemazee and Burki's mice [2] , and newly produced B cells die in mice given anti-immunoglobulin.
When lysozyme is present, not on cell surfaces but as a soluble protein in moderate concentrations in the body fluids, lysozyme-specific B cells do survive and leave the marrow. Large numbers of these cells are found in the secondary lymphoid organs, but they are not able to mount an antibody response against lysozyme. This lack of response was shown to be attributable to B-cell unresponsiveness (anergy), over and above the effect of T-cell tolerance (unresponsiveness or cell deletion) to lysozyme. Goodnow and colleagues have published several papers on the nature and extent of this B-cell anergy and its potential for reversal (reviewed in [5] ). They find that a much lower concentration of secreted lysozyme, calculated to occupy fewer than 5% of the anti-lysozyme receptors on B cells, has no obvious effect on the development of lysozyme-specific B cells, which can be recruited into responses to antigenic doses of lysozyme.
It is not obvious that the peripheral B-cell pool of normal, healthy individuals contains substantial numbers of naturally occurring anergic B cells with specificity for autoantigens. A series of experiments by Cyster and colleagues [6] indicates that, in normal mice, cells equivalent to the anergic anti-lysozyme cells found in the triple transgenic mice have a very poor chance of surviving. In order to provide an environment containing a mixture of self-reactive and normal cells, they constructed mice with chimaeric bone marrow derived from various combinations of lysozyme-expressing or anti-lysozyme-expressing transgenic and normal mice ( Table 2) .
In chimaeric mice, the newly produced virgin B cells carrying the transgenically encoded anti-lysozyme immunoglobulin on their surface, and the B cells with normally encoded surface immunoglobulin, seemed equally capable of migrating from the marrow to the spleen. In the spleen the lysozyme-specific B cells were confined to the T zones, areas rich in T cells and antigen-presenting cells. In the chimaeras in which lysozyme was constitutively expressed in soluble form, the antilysozyme B cells seemed to die in this zone without entering the area of the lymphoid follicles. The follicular B cells were recruited from 'normal' cells not carrying the transgene.
This outcome is different from that in the lysozyme/antilysozyme transgenic mice, in which all B cells carried the anti-lysozyme surface receptor. In that situation, the anergic B cells did colonize the follicles, but did not progress to colonize a third peripheral B-cell compartment -the marginal zone [7] . It seems that, in the presence of large numbers of non-autoreactive B cells, anergic self-reactive B cells have little chance of surviving beyond the initial stages in the secondary lymphoid organs.
How do these results tie in with what we know about B-cell development and progression through lymphoid tissues? A normal B cell can pass through three maturation stages without undergoing antigen-driven proliferation. This progression is .from newly produced virgin B cell to recirculating follicular B cell, and finally to nonrecirculating marginal zone B cell (Fig. 1) [8] . Newly produced virgin B cells are found in the marrow, but they also migrate through the blood to the T zones of secondary lymphoid organs [9] . The T zones are sites where a virgin B cell that has bound antigen can make an antigen-specific interaction with a T cell, resulting in antibody production. B cells that have taken up antigen internalize it, break it down to peptides and then present the resulting peptides on their surface in association with class II MHC molecules. On entering the T zone, a B cell that has processed antigen seeks out particular T cells that cluster in this zone after they too have been activated Most newly produced virgin B cells die in secondary lymphoid tissue about three days after they first express surface immunoglobulin in the bone marrow [9] . A few survive, either by being recruited into an antibody response or by maturing to become recirculating B cells [8] . Recirculating cells migrate between the secondary lymphoid organs, which they enter from the blood. In the lymphoid tissues they pass through the T zones to the follicles and then return to the blood, usually via the lymphatic system [11] . If all the newly produced virgin B cells produced from haemopoietic cells in the marrow were recruited into the recirculating pool of B cells, this pool would be renewed about every four days [8] . In practice, the average life span of recirculating B cells in normal adult rodents is of the order of a month or two (reviewed in [12] ).
by interaction with antigen held on the specialized dendritic antigen-presenting cells found in T zones [10] . If the B cell finds an activated cognate T cell, it then starts to proliferate and differentiate. A B cell that has bound an autoantigen is very unlikely to find a specific helper T cell, for autoreactive T cells are normally eliminated by a rigorous selection process [10] .
The brief life-span of most virgin B cells is due to the newly produced cells being deleted because of excess production, and not because a high proportion of the cells are autoreactive. This is illustrated by the dramatic increase in recruitment of newly produced cells to the recirculating pool that occurs when recirculating cells are selectively depleted [13] . The increase in recruitment can rise to a level where a high proportion of the marrow output of B cells become recirculating cells. These cells are not anergic, as they are in the lysozyme/antilysozyme transgenic mice, and the marginal zones refill with a lag of about three days after cells enter the recirculating pool. The rapid rate of replenishment is due to a decreased rate of death in newly produced virgin B cells, and not to B-cell proliferation. On the other hand, Gu et al. [14] found that the antigen-binding repertoire of peripheral pool B cells of normal mice is more restricted than the repertoire of bone marrow B cells, indicating that some process of selection takes place. The difference was not marked in germ-free mice, suggesting that environmental antigens might influence selection of the normal repertoire of antigen receptors carried in the Nothing is known of the mechanism that assesses the size of the recirculating B cell pool and recruits sufficient new B cells to maintain its numbers. One can speculate that assessment might be carried out by a cell located in the T zone, a site visited both by recirculating cells and newly produced virgin B cells. Counting and recruitment could be achieved if, firstly, the counting-recruiting cell expresses a dominant receptor that is specific for a molecule present on the surface of all recirculating B cells. Secondly, engagement of the dominant receptor by recirculating B cells inhibits the expression of a second receptor, specific for a molecule on newly produced virgin B cells; loss of recirculating cells would result in the expression of the second receptor. Thirdly, newly produced virgin B cells engaging the second receptor receive a signal that causes them to differentiate into recirculating cells.
The new virgin B cells that have taken up antigen seek out primed T cells in the T zone. In a scheme of the type described above, it may be that this diverts them from attempting to engage the second receptor on the hypothetical counting-selection cells. In the artificial transgenic system, where all B cells have taken up antigen, there would be no cells specifically seeking out the counting-selection cells and some of the newly produced B cells expressing anti-lysozyme would be expected to engage the second receptor and so become recirculating cells.
The experiments in transgenic mice have shown that autoreactive B cells compete poorly for slots in the recirculating B-cell pool, but there is a back-up mechanism that induces rare persistent autoreactive cells to become unresponsive to antigen. How do these powerful mechanisms that induce B-cell tolerance to autoantigens fail in patients who produce pathogenic autoantibodies? Perhaps the most likely mechanism is the breakdown of T-cell tolerance, allowing autoreactive newly produced virgin B cells to receive help from T cells in the T zones.
